Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Breakthrough Genomics, |
RCV004596326 | SCV005088840 | likely pathogenic | Rubinstein-Taybi syndrome due to CREBBP mutations | 2020-08-21 | criteria provided, single submitter | clinical testing | This variant is predicted to cause a frameshift and consequent premature termination of the protein and the resultant protein will likely to lack TRERF1 interaction region [Uniprot] of the protein; this will likely result in loss-of-function. This variant has not been previously reported in population databases or in the literature. However, several other truncating variants such as; p.Pro1953fs and p.Glu1957fs lying downstream of the variant, have been previously reported as ‘pathogenic’ in the context of Rubinstein-Taybi syndrome. |
Gharavi Laboratory, |
RCV000681762 | SCV000809221 | likely pathogenic | not provided | 2018-09-16 | no assertion criteria provided | research |